Investigating the development and therapeutic potential of intra-tumoral CXCR6+ effector/effector memory T cells (TEFF/EM) in triple-negative breast cancer

被引:0
|
作者
Lim, Bryan Jian Wei
Wang, Xiao-Fan
Li, Qi-Jing
机构
关键词
D O I
10.1158/1538-7445.AM2023-5083
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5083
引用
收藏
页数:2
相关论文
共 38 条
  • [1] Triple-negative breast cancer: investigating potential molecular therapeutic target
    Papa, Anselmo
    Caruso, Davide
    Tomao, Silverio
    Rossi, Luigi
    Zaccarelli, Eleonora
    Tomao, Federica
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (01) : 55 - 75
  • [2] Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillance (vol 24, 6, 2025)
    Mai, Zhikai
    Fu, Liwu
    Su, Jiyan
    To, Kenneth K. W.
    Yang, Chuansheng
    Xia, Chenglai
    MOLECULAR CANCER, 2025, 24 (01)
  • [3] Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients
    Yves Boucher
    Ashwin S. Kumar
    Jessica M. Posada
    Evisa Gjini
    Kathleen Pfaff
    Mikel Lipschitz
    Ana Lako
    Dan G. Duda
    Scott J. Rodig
    F. Stephen Hodi
    Rakesh K. Jain
    npj Precision Oncology, 5
  • [4] Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients
    Boucher, Yves
    Kumar, Ashwin S.
    Posada, Jessica M.
    Gjini, Evisa
    Pfaff, Kathleen
    Lipschitz, Mikel
    Lako, Ana
    Duda, Dan G.
    Rodig, Scott J.
    Hodi, F. Stephen
    Jain, Rakesh K.
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [5] Intra-tumoral infiltration of GZMKhigh CD8+ T effector memory cells is associated with poor clinical outcome in early-stage colo-rectal cancer
    Tiberti, Silvia
    Catozzi, Carlotta
    Scirgolea, Caterina
    Croci, Ottavio
    Cagnina, Danilo
    Campaner, Stefano
    Shaefer, Martin
    Fazio, Nicola
    Fumagalli-Romario, Uberto
    Ren, Guangwen
    Lugli, Enrico
    Nezi, Luigi O.
    Manzo, Teresa
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [6] CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
    Fattori, Stephane
    Le Roy, Aude
    Houacine, Jemila
    Robert, Lucie
    Abes, Riad
    Gorvel, Laurent
    Granjeaud, Samuel
    Rouviere, Marie-Sarah
    Ben Amara, Amira
    Boucherit, Nicolas
    Tarpin, Carole
    Pakradouni, Jihane
    Charafe-Jauffret, Emmanuelle
    Houvenaeghel, Gilles
    Lambaudie, Eric
    Bertucci, Francois
    Rochigneux, Philippe
    Goncalves, Anthony
    Foussat, Arnaud
    Chretien, Anne-Sophie
    Olive, Daniel
    CANCER RESEARCH, 2023, 83 (18) : 3026 - 3044
  • [7] Exploring potential molecular targets and therapeutic efficacy of beauvericin in triple-negative breast cancer cells
    Patra, Arupam
    Ghosh, Siddhartha Sankar
    Saini, Gurvinder Kaur
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2024, 112
  • [8] Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function
    Ren, Zhiqiang
    Xue, Yinyin
    Liu, Liang
    Zhang, Xuesai
    Pei, Jinpeng
    Zhang, Yu
    Wang, Yue
    Yu, Ker
    CANCER LETTERS, 2023, 565
  • [9] Regulation of mitochondrial fusion and mitophagy by intra-tumoral delivery of membrane-fused mitochondria or Midiv-1 enhances sensitivity to doxorubicin in triple-negative breast cancer
    Chang, Jui-Chih
    Chang, Huei-Shin
    Yeh, Cheng-Yi
    Chang, Hui-Ju
    Cheng, Wen-Ling
    Lin, Ta-Tsung
    Liu, Chin-San
    Chen, Shou-Tung
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [10] Effector memory cytotoxic CD3+/CD8+/CD45RO+ T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancer
    Sun, Xiangjie
    Zhai, Jie
    Sun, Baohua
    Parra, Edwin Roger
    Jiang, Mei
    Ma, Wencai
    Wang, Jing
    Kang, Anthony M.
    Kannan, Kasthuri
    Pandurengan, Renganayaki
    Zhang, Shanyu
    Solis, Luisa Maren
    Haymaker, Cara L.
    Raso, Maria Gabriela
    Perez, Julia Mendoza
    Sahin, Aysegul A.
    Wistuba, Ignacio I.
    Yam, Clinton
    Litton, Jennifer K.
    Yang, Fei
    MODERN PATHOLOGY, 2022, 35 (05) : 601 - 608